An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial-Reference-Cited by-同舟云学术

An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial

Published:2007-08-02 Issue:18 Volume:28 Page:2200-2207
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:European Heart Journal

Author:

Wang T. H.,Bhatt D. L.,Fox K. A.A.,Steinhubl S. R.,Brennan D. M.,Hacke W.,Mak K.-H.,Pearson T. A.,Boden W. E.,Steg P. G.,Flather M. D.,Montalescot G.,Topol E. J.,

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/28/18/2200/1192454/ehm274.pdf

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the structure of drug prescriptions in patients with arterial hypertension and atrial fibrillation in conditions of comorbidity and their compliance with the STOPP/START criteria;"Arterial’naya Gipertenziya" ("Arterial Hypertension");2022-08-15

2. Antiplatelet agents for chronic kidney disease;Cochrane Database of Systematic Reviews;2022-02-28

3. Artificial-Intelligence-Assisted Discovery of Genetic Factors for Precision Medicine of Antiplatelet Therapy in Diabetic Peripheral Artery Disease;Biomedicines;2022-01-06

4. Antithrombotic treatment of asymptomatic carotid atherosclerosis: a medical dilemma;Internal and Emergency Medicine;2020-05-13

5. Analysis of drug prescription appropriateness according to the STOPP/START criteria of the elderly patients with type 2 diabetes mellitus in the endocrinology department of a multi-speciality hospital;Russian Journal of Geriatric Medicine;2020-02-14